Efficacy and safety of the combination of reduced duration prophylaxis followed by immuno-guided prophylaxis to prevent cytomegalovirus disease in lung transplant recipients (CYTOCOR STUDY): an open-label, randomised, non-inferiority clinical trial

Efficacy and safety of the combination of reduced duration prophylaxis followed by immuno-guided prophylaxis to prevent cytomegalovirus disease in lung transplant recipients (CYTOCOR STUDY): an open-label, randomised, non-inferiority clinical trial

IntroductionProlonged use of antivirals to prevent the development of cytomegalovirus (CMV) disease in lung transplant patients has been shown to have significant side effects, for which alternatives are being sought to reduce their use. The monitoring of cell immunity against CMV could be an altern...

Full description

Bibliographic Details
Main Authors: Aurora Paez-Vega, Sara Cantisan, José Manuel Vaquero, Elisa Vidal, Antonio Luque-Pineda, María Ángeles Lobo-Acosta, Ana Belén Pérez, Rodrigo Alonso-Moralejo, David Iturbe, Victor Monforte, Isabel Otero-Gonzalez, Amparo Pastor, Piedad Ussetti, Julian Torre-Cisneros
Format: Article
Language:English
Published: BMJ Publishing Group 2019-08-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/9/8/e030648.full

Internet

https://bmjopen.bmj.com/content/9/8/e030648.full

Similar Items